 SOUTH SAN FRANCISCO, Calif., Aug. 02, 2022 GLOBE NEWSWIRE -- Day One Biopharmaceuticals Nasdaq: DAWN, a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced that management will participate in a panel discussion at the 2022 Wedbush PacGrow Healthcare Virtual Conference. The panel entitled Bullseye - Targeted Oncology - Finding Needles in Plain Sight will be held on Tuesday, August 9 at 10:55 a.m. ET. 